GAD-65/67 Polyclonal Antibody

GAD1 encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. Glutamate decarboxylase 1 is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form.

Introducing the GAD-65/67 Polyclonal Antibody, a cutting-edge immunological tool designed to facilitate accurate and reliable detection of glutamic acid decarboxylase (GAD) isoforms 65 and 67. This meticulously crafted antibody is meticulously developed using state-of-the-art techniques, ensuring exceptional specificity and sensitivity for GAD-65/67 detection in various biological samples.

The GAD-65/67 Polyclonal Antibody boasts an impressive affinity for GAD-65 and GAD-67 proteins, enabling precise identification and quantification of these crucial biomarkers. Its exceptional performance is attributed to the rigorous purification process, which guarantees minimal cross-reactivity with non-target proteins, thereby minimizing false-positive results.

This antibody's versatility is further exemplified by its compatibility with a wide range of applications, including immunohistochemistry, western blotting, and enzyme-linked immunosorbent assays (ELISA). Its robust performance across these platforms ensures seamless integration into diverse research settings, facilitating comprehensive investigations into GAD-65/67 expression and function.

Furthermore, the GAD-65/67 Polyclonal Antibody exhibits exceptional stability and longevity, allowing for prolonged storage without compromising its efficacy. This attribute not only enhances convenience but also ensures consistent and reproducible results, even after extended periods of storage.

In summary, the GAD-65/67 Polyclonal Antibody represents a breakthrough in immunological research, offering unparalleled specificity, sensitivity, and versatility for the detection and quantification of GAD-65 and GAD-67 proteins. With its exceptional performance and long-lasting stability, this antibody is an indispensable tool for scientists and researchers seeking to unravel the intricate mechanisms underlying GAD isoforms and their implications in various physiological and pathological processes.